Cover Image
市場調查報告書

印度的非侵入式產前檢查(NIPT)的新市場

Emerging Indian NIPT Market

出版商 RNCOS E-Services Pvt. Ltd. 商品編碼 296319
出版日期 內容資訊 英文 110 Pages
訂單完成後即時交付
價格
Back to Top
印度的非侵入式產前檢查(NIPT)的新市場 Emerging Indian NIPT Market
出版日期: 2014年02月01日 內容資訊: 英文 110 Pages
簡介

非侵入式產檢查(NIPT)這個新的產前檢查技術正從美國迅速普及到歐洲、亞太地區。中國、日本、澳洲等市場也正在急速成長,但無論哪一個企業都未能打入印度市場,該國的市場仍是個未開拓市場。未來預計在受到體外受精(IVF)的普及,及治療不孕症的醫療觀光、病理分析服務·網路的迅速擴大等要素影響下,印度的NIPT也將急速普及。

本報告提供印度的非侵入式產前檢查(NIPT)市場未來展望相關分析,提供您NIPT技術概要和種類,印度國內的經濟·醫療基礎設施,該國的潛在市場規模·機會,法規環境,主要的NIPT企業及病理分析服務·體外受精服務企業簡介等資訊,為您概述為以下內容。

第1章 分析師的見解

第2章 分析方法

第3章 非侵入式的產前檢查(NIPT)概要

  • MaterniT21 PLUS
  • Verifi
  • Panorama
  • Harmony
  • NIFTY(非侵入性胎兒游離DNA檢查)
  • Bambni

第4章 胎兒的唐氏症風險與母親年齡的關聯性

第5章 印度的宏觀經濟要素,醫療基礎設施,人口結構

  • 該國簡介
  • 醫療費用支出額
  • 醫院·分部中心·基層醫療保健(PHC)·地區醫療中心(CHC)
  • 病理檢驗所
  • 體外受精診所
  • 人口

第6章 印度的NIPT:潛在的市場

  • 潛在的客戶基群
  • 外資型企業的打入市場策略
    • 應該在印度國內設置研究所,還是將樣品發送回本國?
    • 何者將成為面對客戶的窗口(當地洽詢處)?
    • 如何吸引消費者?
  • 印度的婦產科的NIPT預測:調查結果
    • 調查受訪者的特徵
    • 產前檢查相關目前課題:印度市場情況
    • 對NIPT的認識水準
    • 婦產科醫生的見解

第7章 法規方案

第8章 主要NIPT企業

  • Ariosa Diagnostics
    • 產業概要
    • 競爭上的優勢·弱點
  • Sequenom
  • Verinata
  • Natera
  • BGI
  • Berry Genomics

第9章 印度的病理檢驗服務市場主要企業

  • SRL Diagnostics
  • Dr. Lal Pathlabs
  • Metropolis India
  • Thyrocare
  • Quest Diagnostics

第10章 印度的主要體外受精(IVF)診所

  • Bourn Hall Clinic
  • Southend Fertility and IVF Centre
  • Morpheus IVF Fertility Center
  • Bloom Fertility Center
  • Manipal Ankur
  • Cloudnine Fertility
  • Nova IVI Fertility
  • Srushti Test Tube Baby Center

圖表一覽

目錄

Our dedicated team of industry experts intensively monitored and analyzed all the emerging trends in the global molecular diagnostics market. According to their assessment, NIPT has fast emerged as the quickest growing segment. Players, who are actively establishing their base in the US, are also fanning out to the EU and APAC regions. Interestingly, despite catching up on the Chinese, Japanese and Australian markets, players are yet to enter the Indian market. This report has been made to act as a pristine source of business intelligence for players looking to enter the highly lucrative Indian NIPT market.

In their latest research study "Emerging Indian NIPT Market", RNCOS analysts have identified various factors to showcase the immense potential of the Indian NIPT market. These factors like the number of births by the age of mother, rural and urban split of such births; affordability for NIPT; and regulatory scenario have been prudently analyzed to reflect a clear picture of the immense possibilities in the Indian NIPT market.

The report provides a depiction of macro-economic factors and healthcare infrastructure relevant in the context of NIPT. Our study reveals that in India, NIPT will be eagerly adopted by the booming IVF clinics that are witnessing a huge surge in fertility tourism. Also, India is home to a rapidly expanding network of pathology labs. In order to differentiate themselves from competition, organized players in the Indian diagnostic services market are looking forward to adopting new tests.

RNCOS has used its expertise in the Indian IVF and diagnostic services market to provide a relevant snapshot of these markets in the report. Leading players in both markets have been profiled with details about their infrastructure and analysis of their strengths and weaknesses, which will prove to be of value to NIPT players looking for partnering opportunities in India. Besides, to offer a glimpse of NIPT players in the global market to the diagnostic services players looking forward for partnerships and collaborations, detailed profiling of NIPT players, including the description of their test offering along with strengths and weaknesses analysis of their NIPT business has been provided.

The report also includes the findings from another RNCOS survey namely "Gynecologists survey to assess the potential for NIPT in India." The survey was done between September-December 2012 with around 100 leading gynecologists in India. The key findings reveal that currently the awareness level of NIPT is very low in India. But when made aware about the benefits of NIPT, all gynecologists agreed that if launched tactfully, such a technology would have a tremendous scope to revolutionize the prenatal diagnosis scenario in India.

Insights from analysts will prove to be invaluable for NIPT players looking forward to entering the Indian market. Analysts have prudently assessed various factors to critically evaluate different possible business models and device apt marketing strategies. The report is a must buy for all players interested in the Indian NIPT market.

Table of Contents

1. Analyst View

2. Research Methodology

3. Introduction to Non-Invasive Prenatal Testing (NIPT)

  • 3.1 MaterniT21 PLUS
  • 3.2 Verifi
  • 3.3 Panorama
  • 3.4 Harmony
  • 3.5 NIFTY
  • 3.6 Bambni

4. Association of Down's syndrome Risk to Fetus with Mother's Age

5. India: Macro-Economic Factors, Healthcare Infrastructure and Population Demographics

  • 5.1 Country Profile
  • 5.2 Healthcare Spending
  • 5.3 Hospitals, Sub-Centres, PHCs, CHCs
  • 5.4 Pathology Labs
  • 5.5 In-Vitro Fertilization Clinics
  • 5.6 Population

6. NIPT India: Market Potential

  • 6.1 Potential Customer Base
  • 6.2 Market Entry Strategy for Foreign Players
    • 6.2.1 Whether one should Setup a Lab in India or Send Samples to Base Country?
    • 6.2.2 Who should be Company's Face to Customer?
    • 6.2.3 How should the Consumer be Allured?
  • 6.3 Gynecologists and Obstetricians Outlook on NIPT in India: Survey Findings
    • 6.3.1 Respondent Demographics
    • 6.3.2 Current Challenges of Prenatal Testing: Indian Scenario
    • 6.3.3 Awareness Level for NIPT
    • 6.3.4 Gynecologists and Obstetricians Opinion

7. Regulatory Scenario

8. Key NIPT Players

  • 8.1 Ariosa Diagnostics
    • 8.1.1 Business Overview
    • 8.1.2 Strengths and Weaknesses
  • 8.2 Sequenom
    • 8.2.1 Business Overview
    • 8.2.2 Strengths and Weaknesses
  • 8.3 Verinata
    • 8.3.1 Business Overview
    • 8.3.2 Strengths and Weaknesses
  • 8.4 Natera
    • 8.4.1 Business Overview
    • 8.4.2 Strengths and Weaknesses
  • 8.5 BGI
    • 8.5.1 Business Overview
    • 8.5.2 Strengths and Weaknesses
  • 8.6 Berry Genomics
    • 8.6.1 Business Overview
    • 8.6.2 Strengths and Weaknesses

9. Key Players in Indian Pathological Services Market

  • 9.1 SRL Diagnostics
    • 9.1.1 Business Overview
    • 9.1.2 Strengths and Weaknesses
  • 9.2 Dr. Lal Pathlabs
    • 9.2.1 Business Overview
    • 9.2.2 Strengths and Weaknesses
  • 9.3 Metropolis India
    • 9.3.1 Business Overview
    • 9.3.2 Strengths and Weaknesses
  • 9.4 Thyrocare
    • 9.4.1 Business Overview
    • 9.4.2 Strengths and Weaknesses
  • 9.5 Quest Diagnostics
    • 9.5.1 Business Overview
    • 9.5.2 Strengths and Weaknesses

10. Key IVF Clinics in India

  • 10.1 Bourn Hall Clinic
    • 10.1.1 Business Overview
    • 10.1.2 Strengths and Weaknesses
  • 10.2 Southend Fertility and IVF Centre
    • 10.2.1 Business Overview
    • 10.2.2 Strengths and Weaknesses
  • 10.3 Morpheus IVF Fertility Center
    • 10.3.1 Business Overview
    • 10.3.2 Strengths and Weaknesses
  • 10.4 Bloom Fertility Center
    • 10.4.1 Business Overview
    • 10.4.2 Strengths and Weaknesses
  • 10.5 Manipal Ankur
    • 10.5.1 Business Overview
    • 10.5.2 Strengths and Weaknesses
  • 10.6 Cloudnine Fertility
    • 10.6.1 Business Overview
    • 10.6.2 Strengths and Weaknesses
  • 10.7 Nova IVI Fertility
    • 10.7.1 Business Overview
    • 10.7.2 Strengths and Weaknesses
  • 10.8 Srushti Test Tube Baby Center
    • 10.8.1 Business Overview
    • 10.8.2 Strengths and Weaknesses

List of Figures

  • Figure 3-1: MaterniT21 PLUS Test Validation Results
  • Figure 3-2: Verifi Test Validation Results
  • Figure 3-3: Panorma Test Validation Results
  • Figure 3-4: Harmony Test Validation Results
  • Figure 3-5: NIFTY Test - Summary of Phase I Clinical Trial
  • Figure 3-6: NIFTY Test - Summary of Phase II Clinical Trial
  • Figure 4-1: Risk of Down's syndrome with Rise in Maternal Age
  • Figure 5-1: Healthcare Spending (US$ per head), 2013-2018
  • Figure 5-2: Consumer Healthcare Spending (Billion US$), 2013-2018
  • Figure 5-3: Share of Diagnostic Services in Total Healthcare Expenditure (2013)
  • Figure 5-4: Breakup of Public Hospitals by Urban and Rural India (%), 2012
  • Figure 5-5: Breakup of Public Hospitals Beds by Urban and Rural India (%), 2012
  • Figure 5-6: Forecast for Share of Organized Pathology Services Market (2018)
  • Figure 5-7: IVF Clinics Presence by Number of Cycles Performed (%), 2013
  • Figure 5-8: IVF Clinics Presence by Number of Cycles Performed and Structure (%), 2013
  • Figure 5- 9: Population (Million), 2013-2018
  • Figure 5-10: Middle Class Population (Million), 2013-2018
  • Figure 6-1: India - Number of Births (Million), 2013-2018
  • Figure 6-2: India - Number of Births by Mother's Risk of Down's Syndrome (%), 2013
  • Figure 6-3: Number of Households Earning more than US$ 10,000 Per Annum (Million) 2013-2018
  • Figure 6-4: Factors Influencing the Indian NIPT Consumer
  • Figure 6-5: Respondent Gynecologists by Tier
  • Figure 6-6: Respondent Gynecologists by Region
  • Figure 6-7: Recommendations for Amniocentesis/CVS per Year
  • Figure 6-8: Challenges with Invasive Prenatal Tests
  • Figure 6-9: Are you Aware of DNA sequencing Based Non-Invasive Prenatal Tests (NIPT)?
  • Figure 6-10: Are you Aware of Technology used in NIPT?
  • Figure 6-11: What NIPT Players are you Aware of?
  • Figure 6-12: Respondents Who are Interested in NIPT Post Being Made Aware about its Advantages
  • Figure 6-13: Age-Based Profile of Patient to Whom Respondents will Recommend NIPT
  • Figure 6-14: Respondents Who Recommend Integration of NIPT with Regular Maternal Screens

List of Tables

  • Table 3-1: Comparison of Features of Key NIPT Tests in APAC NIPT Market
  • Table 3-2: Bambni Test - Summary of Phase I Clinical Trial
  • Table 3-3: Bambni Test - Summary of Phase II Clinical Trial
  • Table 5-1: Key Economic Indicators (2012)
  • Table 5-2: State-wise Breakup of Government Hospitals and Hospital Beds (2012)
  • Table 5-3: State-wise Breakup of Sub Centres, PHCs and CHCs (2012)
  • Table 5-4: Population Break-up by Age-Group (Million), 2013-2018
  • Table 6-1: India - Number of Births by Age of Mother and Region of Birth (2013)
  • Table 6-2: India - NIPT Potential Market (Million US$) and Potential Customers (2013)
  • Table 10-1: Presence of Bourn Hall Clinic
  • Table 10-2: Presence of Southend Fertility and IVF Center
  • Table 10-3: Presence of Morpheus IVF Fertility Center
  • Table 10-4: Presence of Bloom Fertility Center
  • Table 10-5: Presence of Manipal Ankur
  • Table 10-6: Presence of Cloudnine Fertility
  • Table 10-7: Presence of Nova IVI Fertility
  • Table 10-8: Presence of Srushti Test Tube Centre
Back to Top